mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |